To assess the safety, tolerability, and immunogenicity of izokibep in subjects with active non-infectious, intermediate-, posterior- or pan-uveitis requiring high-dose steroids.
Amy Pikalek
GALE
To assess the long-term efficacy and safety of multiple intravitreal injections of APL-2 in subjects with geographic atrophy secondary to age-related macular degeneration.
CONCERTO
To determine the safety and effectiveness of the smaller incision, new generation (SING), implantable miniature telescope (IMT) in patients with moderate-severe central vision loss due to late-stage age-related macular degeneration (AMD).
VILLA
To evaluate safety and tolerability of the Port Delivery System (PDS) in patients with neovascular age-related macular degeneration (nAMD).
HONU
The purpose of this study is to assess iAMD disease progression, by the timeline and rates of conversion for high-risk iAMD at baseline to more advanced AMD stages.
Terri L. Young, MD, MBA Receives Prestigious Women in Ophthalmology Award
Terri L. Young, MD, MBA has devoted her career to advancing the voices of women and underserved minorities in the field of ophthalmology. She was honored for this work by the Women in Ophthalmology (WIO) …
Roomasa Channa, MD Named to Ophthalmology Management’s 40 Under 40
Amazing. That is how Roomasa Channa, MD of the University of Wisconsin Department of Ophthalmology and Visual Sciences is being described. At a special reception at the American Academy of Ophthalmology (AAO) annual meeting in …
New Pediatric Ophthalmology Rotation Announced
The UW Department of Ophthalmology and Visual Sciences is pleased to announce a new pediatric ophthalmology rotation. The new three-week rotation, which officially launched in September 2022, is designed to address the critical shortage of …
Department Activity at 2022 American Academy of Ophthalmology Annual Meeting
Join the faculty of the University of Wisconsin Department of Ophthalmology and Visual Sciences at the 2022 American Academy of Ophthalmology Annual Meeting in Chicago September 30- October 1 as we connect, share, and advance our …